Luljeta Abdullahu¹* and Naser Gjonbalaj²

¹Department of Nuclear Medicine, University Clinical Center of Kosova, Republic of Kosovo
²Clinic of Radiology, Prishtina Republic of Kosova, University Clinical Center of Kosova, Republic of Kosovo

*Corresponding Author: Luljeta Abdullahu, Department of Nuclear Medicine, University Clinical Center of Kosova, Republic of Kosovo.

Received: July 26, 2021; Published: August 24, 2021

Citation: Luljeta Abdullahu and Naser Gjonbalaj. “Detection and Localization of Parathyroid Adenoma and its Consequences in a Patient with Primary Hyperparathyroidism". Acta Scientific Microbiology 5.9 (2021): 131-135.

Abstract

Background: Hepatitis-B virus (HBV) infection among people living with HIV (PLWH) is highly endemic in South Africa. Despite the availability of an effective vaccine for the last three decades, chronic HBV infection is a major cause of morbidity and mortality among PLWH. Although the majority of opportunistic infection has been reduced in an individual with HIV since the universal test and treat (UTT) programme implemented in South Africa. HBV co-infection among PLWH is still accounting for high morbidity and mortality in South Africa.

Methodology: This cross-sectional descriptive survey was conducted in King Sabata Dalindyebo (KSD) sub-district municipality in the Eastern Cape Province of South Africa to determine the prevalence of HBV Co-infection among people living with HIV.

Results: There were 602 PLWH participated in the study and two-third (65.5%) of them had screened for HBV coinfection. The mean age of the participant was 38.8 ± 10.5 years and the majority (75.1%) of them were female. The prevalence of HBV coinfection among PLWH was 12.2% and the males had three-time higher than female counterparts (χ² = 12.8, p = 0.001). The HBV coinfection was more common among PLWH, who use alcohol, tobacco, and cannabis. The median CD4 count of participants was 508 (IQR = 307 to 715) and there was no significant association between HBV coinfection and CD4 count.

Conclusion: There is a high prevalence of HBV coinfection among PLWH in the Mthatha region of South Africa. The high prevalence of HBV coinfection recommends the need for routine screening of Hepatitis-B among HIV infected patients in South Africa.

Keywords: HBV; HIV; PLWH; UTT; Morbidity and Mortality

Bibliography

1. Spearman CW., et al. “Hepatitis B in sub-Saharan Africa: strategies to achieve the 2030 elimination targets”. Lancet Gastroenterology and Hepatology12 (2017): 900-909.
2. “Global hepatitis report” (2017).
3. Bigna JJ., et al. “Hepatitis B virus and HIV coinfection among adults residing in Cameroon: A systematic review and meta-analysis of prevalence studies”. Infection, Disease and Health3 (2018): 170-178.
4. Andersson MI., et al. “The epidemiology of hepatitis B virus infection in HIV-infected and HIV-uninfected pregnant women in the Western Cape, South Africa”. Vaccine47 (2013): 5579-5584.
5. Matthews PC., et al. “Epidemiology and impact of HIV coinfection with Hepatitis B and Hepatitis C viruses in Sub-Saharan Africa”. Journal of Clinical Virology1 (2014): 20-33.
6. Mayaphi SH., et al. “HBV/HIV co-infection: The dynamics of HBV in South African patients with AIDS”. South African Medical Journal3 (2012): 157-162.
7. Stabinski L., et al. “Prevalence of HIV and Hepatitis B virus co-infection in Sub-Saharan Africa and the potential impact and program feasibility of Hepatitis B surface antigen screening in resource-limited settings”. Journal of Acquired Immune Deficiency Syndromes 68 (2015): S274-285.
8. Chonco F and Rangiah S. “Susceptibility to hepatitis B infection, hepatitis B/HIV co-infections and hepatitis B immunity in HIV-positive patients starting HAART in Durban, South Africa”. South African Family Practice 2 (2019): 65-68.
9. Hønge BL., et al. “Hepatitis B and Delta Virus Are Prevalent but Often Subclinical Co-Infections among HIV Infected Patients in Guinea-Bissau, West Africa: A Cross-Sectional Study”. Chemin IA, editor. PLoS One6 (2014): e99971.
10. Baker L and Pharm D. “The South African Expanded Programme on Immunisation schedule”. Professional Nursing Today4 (2010): 19-22.
11. Ayuk J., et al. “Hepatitis B virus in HIV-infected patients in north-eastern South Africa: Prevalence, exposure, protection and response to HAART”. South African Medical Journal5 (2013): 330.
12. Barth RE., et al. “Hepatitis B/C and HIV in sub-Saharan Africa: an association between highly prevalent infectious diseases. A systematic review and meta-analysis”. International Journal of Infectious Diseases12 (2010): e1024-1031.
13. Martin CE., et al. “Universal Test and Treat policy and adolescents in South Africa” 1 (2017).
14. Jaquet A., et al. “Alcohol use, viral hepatitis and liver fibrosis among HIV-positive persons in West Africa: A cross-sectional study”. Journal of the International AIDS Society 1 (2017): 1-10.

Copyright: © 2021 Ramprakash Kaswa and Marietjie de Villiers. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.